An insufflator for insufflating a body cavity includes a compressed air vessel and a flow control valve for delivering insufflating air to the cavity through a first trocar. A discharge control valve at an outlet port of a second trocar exhausts insufflating air from the cavity. A pressure sensor on the first trocar monitors cavity pressure, and a microcontroller operates the flow control valve for maintaining a predefined working pressure in the cavity. A foot operated switch is operable by a surgeon for opening and closing the discharge control valve. When the pressure in the cavity drops below the predefined working pressure, the flow control valve increases the insufflating air to the cavity, thereby increasing the insufflating air flow through the cavity for removing undesirable gases. The apparatus and insufflator may also be adapted for removing smoke, nitrogen or other undesirable gases during both cauterisation and cryogenic procedures.

An insufflator for insufflating a body cavity includes a compressed air vessel and a flow control valve for delivering insufflating air to the cavity through a first trocar. A discharge control valve at an outlet port of a second trocar exhausts insufflating air from the cavity. A pressure sensor on the first trocar monitors cavity pressure, and a microcontroller operates the flow control valve for maintaining a predefined working pressure in the cavity. A foot operated switch is operable by a surgeon for opening and closing the discharge control valve. When the pressure in the cavity drops below the predefined working pressure, the flow control valve increases the insufflating air to the cavity, thereby increasing the insufflating air flow through the cavity for removing undesirable gases. The apparatus and insufflator may also be adapted for removing smoke, nitrogen or other undesirable gases during both cauterisation and cryogenic procedures.

Disclosed is a drug injection device that is implanted between the skull and the subcutaneous layer of an animal. The disclosed drug injection device includes: a main body that is positioned on the skull and implanted and fixed in the subcutaneous layer; a guide member that guides a trocar such that the drug is injected into brain parenchyma inside the skull of the animal; a cover member that is installed inside the main body and connected to the guide member in the center and has a hole for guiding drug injection trocar so as to be inserted; and a sealing member that is installed between the main body and the cover member and prevents reverse flow of drugs and the introduction of foreign substances.

Disclosed is a drug injection device that is implanted between the skull and the subcutaneous layer of an animal. The disclosed drug injection device includes: a main body that is positioned on the skull and implanted and fixed in the subcutaneous layer; a guide member that guides a trocar such that the drug is injected into brain parenchyma inside the skull of the animal; a cover member that is installed inside the main body and connected to the guide member in the center and has a hole for guiding drug injection trocar so as to be inserted; and a sealing member that is installed between the main body and the cover member and prevents reverse flow of drugs and the introduction of foreign substances.

The present invention relates to a combination of a flexible container of the type with a brush and a tube enclosing a homogeneous suspension composed of an aqueous phase and of an oily phase which has at least one active principle, characterized in that the container has an applicator consisting of friction members suitable for applying said suspension at the outlet of an orifice onto a zone of the body of a subject to be treated, said suspension having a suitable viscosity allowing it to be distributed homogeneously via said members of said applicator.

The present invention relates to a combination of a flexible container of the type with a brush and a tube enclosing a homogeneous suspension composed of an aqueous phase and of an oily phase which has at least one active principle, characterized in that the container has an applicator consisting of friction members suitable for applying said suspension at the outlet of an orifice onto a zone of the body of a subject to be treated, said suspension having a suitable viscosity allowing it to be distributed homogeneously via said members of said applicator.

Provided is a method for treating animals, such as livestock, by exposing the animals to an airborne suspension of finely divided mineral salts. Treatment is effected upon inspiration of the mineral salts or skin contact with the mineral salts. The animals are accommodated in a treatment chamber with a substantially sealed limited confined volume and has a pressure difference airflow means, a dispensing means for the mineral salts and desiccant(s) in the walls and on the floor of the treatment chamber. The treatment chamber is a stationary installation or adapted as a trailer to treat animals during a journey or to transport the treatment chamber to the animals location, for example, a zoo or to apiaries.

Provided is a method for treating animals, such as livestock, by exposing the animals to an airborne suspension of finely divided mineral salts. Treatment is effected upon inspiration of the mineral salts or skin contact with the mineral salts. The animals are accommodated in a treatment chamber with a substantially sealed limited confined volume and has a pressure difference airflow means, a dispensing means for the mineral salts and desiccant(s) in the walls and on the floor of the treatment chamber. The treatment chamber is a stationary installation or adapted as a trailer to treat animals during a journey or to transport the treatment chamber to the animals location, for example, a zoo or to apiaries.

An insufflator for insufflating a body cavity includes a compressed air vessel and a flow control valve for delivering insufflating air to the cavity through a first trocar. A discharge control valve at an outlet port of a second trocar exhausts insufflating air from the cavity. A pressure sensor on the first trocar monitors cavity pressure, and a microcontroller operates the flow control valve for maintaining a predefined working pressure in the cavity. A foot operated switch is operable by a surgeon for opening and closing the discharge control valve. When the pressure in the cavity drops below the predefined working pressure, the flow control valve increases the insufflating air to the cavity, thereby increasing the insufflating air flow through the cavity for removing undesirable gases. The apparatus and insufflator may also be adapted for removing smoke, nitrogen or other undesirable gases during both cauterisation and cryogenic procedures.

An insufflator for insufflating a body cavity includes a compressed air vessel and a flow control valve for delivering insufflating air to the cavity through a first trocar. A discharge control valve at an outlet port of a second trocar exhausts insufflating air from the cavity. A pressure sensor on the first trocar monitors cavity pressure, and a microcontroller operates the flow control valve for maintaining a predefined working pressure in the cavity. A foot operated switch is operable by a surgeon for opening and closing the discharge control valve. When the pressure in the cavity drops below the predefined working pressure, the flow control valve increases the insufflating air to the cavity, thereby increasing the insufflating air flow through the cavity for removing undesirable gases. The apparatus and insufflator may also be adapted for removing smoke, nitrogen or other undesirable gases during both cauterisation and cryogenic procedures.